Related by context. All words. (Click for frequent words.) 69 davalintide 68 AEGR 68 pramlintide 67 Contrave 66 Dapagliflozin 66 pramlintide metreleptin 66 bicifadine 66 zonisamide SR 65 oral rivaroxaban 65 nalbuphine ER 65 PSN# [002] 65 efficacy tolerability 65 APD# 65 tesofensine 65 Contrave# 64 CIMZIA TM 64 QNEXA 64 selective androgen receptor modulator 64 maximally tolerated dose 64 Triolex 64 Traficet EN 64 fenofibric acid 63 LEVADEX 63 teriflunomide 63 Qnexa 63 Oral NKTR 63 CIMZIA ™ 63 visilizumab 63 MAP# 63 Phase 2a trial 63 regorafenib 63 R#/MEM # 63 oral prodrug 63 Bicifadine 63 rolofylline 63 atrasentan 63 riociguat 63 TBC# 63 Firazyr 63 lomitapide 63 urate lowering 62 MoxDuo TM IR 62 RSD# oral 62 JAK inhibitor 62 evaluating tivozanib 62 CoFactor 62 mertansine 62 velafermin 62 elagolix 62 MoxDuo IR 62 MAGE A3 ASCI 62 metformin sulfonylurea 62 DU #b 62 CYCLOSET 62 diabetic neuropathic pain 62 torsemide ER 62 Archexin 62 ZOLINZA 62 torezolid phosphate 62 Panzem R 62 tapentadol ER 62 Ostarine 62 custirsen 62 cangrelor 62 LymphoStat B belimumab 62 Ereska 62 SILENOR 62 KRN# 62 ThGRF 62 apremilast 62 phase IIb clinical 62 incyclinide 62 PRX # 62 Androxal TM 62 QNEXA ® 62 bosutinib 62 MoxDuo ® IR 62 TH# [003] 62 interferon gamma 1b 62 Pimavanserin 62 vidofludimus 62 rNAPc2 61 Dyloject TM 61 Vilazodone 61 SRT# [003] 61 TriRima 61 xanthine oxidase inhibitor 61 AGILECT R 61 Darusentan 61 Tarceva TM 61 PEG PAL 61 Empatic TM 61 ataluren 61 STRIDE PD 61 CANCIDAS 61 CRx 61 CCX# 61 aplindore 61 iniparib 61 Tasimelteon 61 Tyrima 61 Synavive ™ 61 Phase 2a clinical 61 MoxDuo 61 dacetuzumab 61 Ketotransdel 61 ATACAND 61 AZILECT R 61 CIMZIA TM certolizumab pegol 61 Nanobody 61 Corlux 61 Zemplar Capsules 61 oral methylnaltrexone 61 acyclovir Lauriad R 61 Ophena TM 61 BCX# 61 alvimopan 61 LibiGel ® 61 thiazolidinedione 61 ANCHOR trial 61 trodusquemine 61 YONDELIS 61 GSK# [002] 61 leukotriene receptor antagonist 61 Phenoptin 61 metaglidasen 61 Zerenex 61 elotuzumab 61 Rezular 61 taranabant 61 BEMA TM Fentanyl 61 PS# [001] 61 lacosamide 61 investigational humanized monoclonal antibody 61 PREOS R 61 antiplatelet agent 61 Zelrix 61 desvenlafaxine succinate 61 Mipomersen 61 liprotamase 60 Chemophase 60 phase IIa clinical 60 pramlintide metreleptin combination 60 indiplon capsules 60 Lialda 60 Fibrillex TM 60 bupropion SR 60 HuMax EGFr 60 oxymorphone ER 60 lesinurad 60 PDE4 inhibitor 60 forodesine 60 active comparator 60 Diamyd R 60 intranasal formulation 60 DexaSite 60 CYT# QbG# 60 ZEGERID Capsules 60 double blinded placebo 60 Tracleer R 60 Phase 1b trial 60 PRT# 60 lorcaserin 60 LEVADEX ™ 60 Glufosfamide 60 DPP4 60 Phase IIa trial 60 PROMACTA 60 albiglutide 60 Avanafil 60 pharmacodynamic profile 60 adipiplon 60 Naproxcinod 60 muraglitazar 60 insulin sensitizers 60 opioid induced bowel dysfunction 60 BAY #-# 60 Tekamlo 60 sulfonylurea glimepiride 60 APEX PD 60 liposomal formulation 60 ruxolitinib 60 RELOVAIR ™ 60 linagliptin 60 Bezielle 60 trospium 60 mapatumumab 60 Ticagrelor 60 Omigard 60 6R BH4 60 CaPre TM 60 TNF alpha inhibitor 60 Dalbavancin 60 Dextofisopam 60 HGS# 60 pharmacodynamic properties 60 Dabigatran etexilate 60 Q#IR 60 #mg dose [002] 60 dosing cohort 60 Veronate 60 alvespimycin 60 irbesartan 60 NATRECOR R 60 rhIGF-I/rhIGFBP-3 60 NP2 Enkephalin 60 Lorqess 60 AOD# [002] 60 sorafenib tablets 60 Dual Opioid 60 ISIS # 60 SNRI 60 SILENOR TM 60 aflibercept 60 INCB# [001] 60 phase IIb 60 Azedra 60 MNTX 60 Cleviprex TM clevidipine 60 analgesic efficacy 60 ToGA 60 Diabetic Macular Edema 60 tasimelteon 60 Anturol 60 tezampanel 60 EMPOWER ™ 60 aclidinium 60 anidulafungin 60 Aurexis 59 JAK3 inhibitor 59 lumiliximab 59 safinamide 59 peripherally acting 59 HuLuc# 59 REMINYL ® 59 Topiramate 59 lurasidone 59 endothelin antagonist 59 Golimumab 59 oral FTY# 59 methylnaltrexone 59 JANUVIA 59 TELINTRA 59 pertuzumab 59 VA# [002] 59 sunitinib malate 59 QVA# 59 Ramelteon 59 Phase Ib clinical 59 mixed dyslipidemia 59 Targretin 59 tasocitinib 59 tanespimycin 59 Nuvion 59 phase IIb study 59 ADVANCE PD 59 investigational protease inhibitor 59 Factor VIIa 59 TOCOSOL Camptothecin 59 VAPRISOL 59 pomalidomide 59 oral antidiabetic 59 OMNARIS HFA 59 Orexigen Contrave 59 T Pred 59 R sorafenib tablets 59 oxycodone CR 59 TRIOLEX HE# APOPTONE HE# 59 teduglutide 59 Lorcaserin 59 solanezumab 59 statin simvastatin 59 Vernakalant 59 Phase Ib 59 azilsartan medoxomil 59 ELND# 59 Exelixis compounds 59 CINTREDEKIN BESUDOTOX 59 HGS ETR2 59 PRADAXA 59 CINQUIL 59 arzoxifene 59 JANUMET 59 Phase 1b clinical 59 venlafaxine XR 59 Clonicel 59 Hyphanox 59 CTAP# Capsules 59 comparator arm 59 INVEGA ® 59 Teriflunomide 59 OHR/AVR# 59 Tesofensine 59 RLY# 59 ARCOXIA 59 Gabapentin GR 59 COPEGUS 59 sargramostim 59 Candesartan 59 Fodosine 59 #mg dose [003] 59 hour bronchodilation 59 nab paclitaxel 59 DFMO 59 Pruvel 59 brivaracetam 59 SCH # 59 Lu AA# 59 cediranib 59 orlistat Xenical 59 ponatinib 59 plasma kallikrein inhibitor 59 phase Ib 59 ONCONASE R 59 PREOS 59 OMNARIS Nasal Spray 59 PEG SN# 59 achieved statistical significance 59 orBec 59 primary hypercholesterolemia 59 RG# ITMN 59 placebo controlled clinical 59 Pagoclone 59 Icatibant 59 SomatoKine 59 LAF# 59 IMiDs 59 Cimzia TM 59 corticosteroid dexamethasone 59 Aliskiren 59 HCV protease inhibitors 59 adalimumab Humira 59 ACTEMRA TM 59 SinuNase 59 rufinamide 59 balsalazide 59 ACUROX ® 59 exenatide LAR 59 intravenous bisphosphonates 59 CA4P 59 Phase IIb trial 59 Rebif ® 59 Cloretazine R VNP#M 59 Dasatinib 59 Phase 1a clinical 59 AAG geldanamycin analog 59 GSK# [001] 59 insulin detemir 58 ancrod 58 Reclast Aclasta 58 Vaprisol 58 GLYX 58 EVIZON 58 cannabinor 58 NUVIGIL 58 LEVAQUIN ® 58 LY# [003] 58 metreleptin 58 Atrasentan 58 Bifeprunox 58 LIALDA 58 motesanib 58 Histalean TM 58 levetiracetam Keppra 58 posaconazole 58 Starlix 58 enzastaurin 58 thymalfasin 58 TLK# 58 postoperative ileus POI 58 iloperidone 58 Crestor rosuvastatin 58 IMP# 58 TELCYTA 58 Elagolix 58 neratinib 58 Pramlintide 58 MGCD# [002] 58 eprotirome 58 odanacatib 58 ALKS 58 Pioglitazone 58 Anturol TM 58 otelixizumab 58 SIMCOR 58 BRIM2 58 Ixempra 58 ribavirin USP 58 lipid parameters 58 plus prednisone prednisolone 58 SinuNase TM 58 Alzhemed TM 58 Saxagliptin 58 PXD# 58 aleglitazar 58 pharmacodynamic effects 58 Laquinimod 58 midstage clinical 58 iclaprim 58 pseudobulbar affect PBA 58 NGX# 58 NeuroSTAT ® 58 Denufosol 58 phase IIb trial 58 treprostinil 58 Intermezzo R 58 HuMax CD# 58 Tolvaptan 58 vilazodone 58 ARIKACE ™ 58 dexpramipexole 58 ulimorelin 58 idraparinux 58 Phase #b/#a trial 58 oral ridaforolimus 58 Chrysalin 58 pegloticase 58 clazosentan 58 dimebon 58 Phase 2a 58 Synavive 58 Phase 2b clinical 58 sNDA submission 58 Prosaptide 58 deforolimus 58 Meridia sibutramine 58 PYY #-# 58 ibandronate 58 LHRH antagonists 58 DermaVir Patch 58 Ocrelizumab 58 Focalin XR 58 sitaxsentan 58 KAPVAY ™ 58 Increlex ® 58 Ambrisentan 58 Betaferon ® 58 tolerability profiles 58 confirmatory clinical 58 ENMD # 58 Diovan HCT 58 Valdoxan 58 SNT MC# 58 MEND CABG II 58 desvenlafaxine 58 Virulizin ® 58 LY# [002] 58 Vivus Qnexa 58 insulin sensitizing 58 Serdaxin 58 TRILIPIX 58 glufosfamide 58 tipranavir 58 #mg/day [001] 58 UPLYSO 58 orally administered 58 Triapine R 58 ELACYT 58 ocrelizumab 58 pioglitazone HCl 58 Welchol 58 Capesaris 58 APRISO 58 AEG# 58 darapladib 58 CORLUX 58 panitumumab Vectibix 58 Cinquil 58 RhuDex ® 58 multicenter randomized placebo controlled 58 darusentan 58 TRO# 58 tocilizumab 58 Targretin capsules 58 EFAPROXYN 58 docetaxel Taxotere R 58 GLPG# 58 prucalopride 58 eltrombopag 58 celgosivir 58 Elocalcitol 58 Keppra XR 58 ACOMPLIA R 58 ACCORD Lipid 58 selegiline 58 Cethromycin 58 anti amnesic 58 telcagepant 58 Sym# 58 GFT# 58 Elvitegravir 58 Quinamed 58 ruboxistaurin 58 Kinoid 58 sitagliptin Januvia 58 schizophrenia CIAS 58 selective modulator 58 Sitagliptin 58 Poly ICLC 58 tipifarnib 58 novel oral anticoagulant 58 Genz # 58 ATHX 58 Aflibercept 58 budesonide foam 58 neuroprotective properties 58 NATRECOR ® 58 Liraglutide 58 Prodarsan ® 58 Phase IIb clinical 58 divalproex sodium 58 Octreolin 58 candidate TNFerade biologic 58 1mg dose 58 C1 INH 58 Symadex 58 thiazolidinediones TZDs 58 GAMMAGARD 58 TKM ApoB 58 Troxatyl 58 2 methoxyestradiol 58 Glumetza TM 58 pitavastatin 58 TDF FTC 58 direct thrombin inhibitors 58 subcutaneously administered 58 tramiprosate 58 IMC A# 58 Vicriviroc 58 cleavable linker 57 Asentar 57 temsirolimus 57 uric acid lowering 57 Adalimumab 57 Pemetrexed 57 ONTARGET 57 Vandetanib 57 tarenflurbil 57 Tocosol Paclitaxel 57 HQK 57 lorcaserin hydrochloride 57 atacicept 57 CorVue ™ 57 NVA# 57 phase 2a 57 Xanafide 57 ZALBIN dosed 57 KAPIDEX 57 DPP4 inhibitor 57 IRX 2 57 double blinded randomized 57 MEND CABG 57 5 HT2C serotonin 57 ascending dose 57 Maximum Tolerated Dose MTD 57 mTOR kinase 57 cobiprostone 57 oral deforolimus 57 reslizumab 57 PSN# [001] 57 clevidipine 57 zileuton 57 MEK inhibitors 57 ICA # 57 Aeroquin 57 Glypromate 57 PegIntron 57 gemifloxacin 57 GPR# agonist 57 BENICAR HCT 57 IL# PE#QQR 57 Arena lorcaserin 57 PHX# 57 tgAAC# 57 balsalazide tablet 57 vosaroxin 57 Pirfenidone 57 GRALISE 57 Paxil paroxetine 57 lucinactant 57 Phase Ib study 57 Iluvien 57 salmeterol fluticasone 57 GALNS 57 dose cohort 57 tramiprosate Alzhemed TM 57 Menerba 57 HZT 57 investigational drug 57 DDP# 57 rEV# 57 #mg doses [002] 57 MYDICAR ® 57 Muraglitazar 57 intravenously administered 57 NV1FGF 57 alemtuzumab Campath 57 ostarine 57 Stedivaze 57 refractory gout 57 #mg ritonavir 57 Iloperidone 57 novel histone deacetylase 57 Pivotal Phase III 57 canagliflozin 57 glycopyrrolate 57 metoprolol succinate 57 virus HCV protease inhibitor 57 vildagliptin 57 BLOOM DM 57 beclomethasone dipropionate 57 Exforge HCT 57 FOLOTYN ® 57 MTP inhibitor 57 Nasulin 57 either acutely decompensated 57 AeroLEF TM 57 VEGF Trap 57 deferiprone 57 dyslipidemia 57 evaluating Xcytrin 57 SPARLON 57 amphotericin B 57 Keppra R 57 risperidone Risperdal 57 antiepileptics 57 CR# vcMMAE 57 enoximone 57 antidiabetic 57 rilonacept 57 Study GL# 57 GATTEX 57 baminercept 57 nucleotide analog 57 Reverset 57 AZILECT 57 USL# 57 receptor tyrosine kinase inhibitor 57 PEG Interferon lambda 57 Phase 2b study 57 Atacand 57 AIM HIGH 57 fingolimod 57 edoxaban 57 Phase IIa 57 ALGRX 57 Zybrestat 57 Milnacipran 57 tolvaptan 57 HIF PH inhibitors 57 Ferumoxytol 57 APTIVUS 57 investigational compound 57 Surfaxin LS 57 Inhalation Solution 57 Iluvien ® 57 Cycloset 57 LEP ETU 57 TOLAMBA 57 olmesartan 57 Panzem R NCD 57 pazopanib 57 tolerability 57 efficacy endpoint 57 Cardio Vascu Grow 57 canakinumab 57 Emezine 57 severe hypercholesterolemia 57 Fx #A 57 paricalcitol 57 pharmacokinetic profile 57 investigational oral 57 Carvedilol 57 MYDICAR 57 adalimumab 57 zolmitriptan 57 Cimzia ® certolizumab pegol 57 huC# DM4 57 refractory AML 57 NB S# 57 RE LY ® 57 standard chemotherapy regimen 57 erythropoietic 57 Egrifta 57 protease inhibitor PI 57 ADAGIO study 57 vorinostat 57 Zelapar 57 mocetinostat MGCD# 57 Telintra 57 THALOMID 57 Phase IIIb clinical 57 Phase #b/#a clinical 57 confirmatory Phase 3 57 LEXIVA r 57 SANVAR 57 mg TID 57 Acapodene 57 tolerated dose MTD 57 ipratropium bromide 57 AFREZZA 57 blinded randomized placebo controlled 57 gepirone ER 57 5 HT2C receptor 57 angiotensin receptor blocker ARB 57 dirucotide 57 diabetic gastroparesis 57 Ventavis 57 anakinra 57 BZL# 57 NanoCrystal Technology 57 CLIRS trial 57 Phase 1b 57 vandetanib 57 Catena ® 57 Phase #b/#a 57 CIPN 57 LCP AtorFen 57 danoprevir 57 elvitegravir 57 FOSRENOL ® 57 mg doses 57 EndoTAG TM -1 57 sitagliptin 57 RezularTM 57 Neurodex 57 relapsed MM 57 dirucotide MBP# 57 mecamylamine 57 Apixaban 57 APTIVUS r 57 aripiprazole Abilify 57 pharmacokinetic equivalence 57 zileuton CR 57 AzaSite Plus 57 Locteron 57 constipation OIC 57 PREZISTA r 57 oral gallium 57 ZACTIMA 57 erlotinib Tarceva ® 57 administered subcutaneously 57 colesevelam HCl 56 BLA submission 56 tafamidis 56 Fablyn 56 GLP1 agonist 56 eniluracil 56 Syncria 56 Zometa zoledronic acid 56 #ME# 56 Technosphere Insulin 56 ONGLYZA ™ 56 idarubicin 56 rasagiline tablets 56 AGILECT ® 56 eritoran 56 RANK Ligand inhibitor 56 casopitant 56 axitinib 56 MGCD# [001] 56 IMA# 56 fostamatinib 56 Phase III ADT 56 sulodexide 56 Civacir 56 novel VDA molecule 56 Epivir 56 Durezol 56 phase IIa 56 Lysteda 56 AERx iDMS 56 Arcalyst 56 pharmacologically active isomer 56 safety tolerability pharmacokinetic 56 Aptivus ® 56 Natalizumab 56 Phase IIb 56 ISTODAX 56 denufosol 56 renal toxicity 56 Prestara 56 placebo controlled Phase 56 favorable tolerability 56 Eltrombopag 56 Zenvia ™ 56 systemic immunosuppressive drugs 56 Relovair 56 palonosetron 56 PANVAC VF 56 octreotide acetate 56 Qnexa TM 56 PYY 56 azelastine 56 MICARDIS ® 56 tolevamer 56 LT NS# 56 Gralise 56 intermittent dosing 56 Phase Ib II 56 favorable pharmacokinetic profile 56 BYDUREON 56 olanzapine 56 Duloxetine 56 INKP 56 Arikace 56 Carfilzomib 56 RSR# 56 Benlysta belimumab 56 postoperative ileus 56 multicenter Phase III 56 OXi# 56 HoFH 56 TG# [003] 56 bezafibrate 56 placebo controlled randomized 56 orally inhaled migraine 56 Tavocept 56 dopamine partial agonist 56 ULORIC 56 dose escalation Phase 56 LymphoStat B 56 Anacetrapib 56 afatinib 56 pharmacokinetic parameters 56 exenatide 56 Emselex 56 cisplatin vinorelbine 56 RoACTEMRA 56 primary Restless Legs 56 IV APAP 56 MAXY G# 56 AZILECT ® 56 Intravail R 56 FM VP4 56 NOX E# 56 tacrolimus ointment 56 Tezampanel 56 Xinlay 56 zafirlukast 56 Phase IIa clinical 56 secondary efficacy endpoints 56 antiobesity 56 candesartan cilexetil 56 Glybera R 56 chlorambucil 56 hyperphenylalaninemia HPA due 56 Phase IIb trials 56 E2F Decoy 56 LAB CGRP 56 oral diclofenac 56 #D#C# 56 leukotriene receptor antagonists 56 BEMA Buprenorphine 56 intravenous cyclophosphamide 56 HGS ETR1 56 Solzira 56 metformin HCl 56 dexanabinol 56 PORxin TM 56 TASKi2 56 efalizumab 56 octreotide implant 56 CDP# 56 PSMA ADC 56 Zoraxel 56 docetaxel chemotherapy 56 Wellmune WGP 56 MIST II 56 Spiegelmer ® 56 valsartan 56 alogliptin 56 Puricase 56 lasofoxifene 56 eprodisate Fibrillex TM 56 milnacipran 56 sorafenib Nexavar 56 Perforomist ™ Inhalation Solution 56 bazedoxifene 56 Dyloject 56 ELADUR 56 Zoraxel TM 56 ganetespib 56 pradefovir 56 Anidulafungin 56 obatoclax 56 relapsed refractory multiple myeloma 56 Amrubicin 56 Cetrorelix 56 pharmacokinetics PK 56 Rasagiline 56 Lacosamide 56 MAA submission 56 rosuvastatin calcium 56 rALLy clinical trial 56 Glybera 56 NDA resubmission 56 pegylated interferons 56 Lubiprostone 56 INCB# [002] 56 CCX# B 56 postmenopausal osteoporotic women 56 clinical pharmacology studies 56 dose escalation phase 56 pharmacokinetic PK profile 56 timolol maleate 56 Intuniv 56 oral antidiabetic agents 56 LUNESTA brand eszopiclone 56 L PPDS 56 aprepitant 56 Orazol 56 serotonin norepinephrine reuptake inhibitor 56 Phase 2b trial 56 iSONEP 56 Fulvestrant 56 class mGluR5 inhibitor 56 laquinimod 56 daclizumab 56 Itraconazole 56 myopathy rhabdomyolysis 56 regadenoson 56 rabeprazole 56 triglyceride lowering 56 CG# [003] 56 OvaRex ® MAb 56 probiotic supplementation 56 MACUGEN 56 bifeprunox 56 BAL# [002] 56 ocular formulation 56 Relistor 56 Pixuvri 56 ANAVEX #-# [003] 56 mipomersen 56 Sulonex TM 56 PRISTIQ 56 Epanova 56 AZD# 56 TNF inhibitor 56 Kynapid 56 tolerability profile 56 TREDAPTIVE 56 mycophenolate mofetil 56 Betaferon R 56 Cloretazine 56 oral talactoferrin 56 Febuxostat 56 CERVARIX 56 linaclotide 56 Relivar 56 Vectibix panitumumab 56 SUCCEED trial 56 Byetta exenatide 56 tapentadol IR 56 Ceplene/IL-2 56 menadione 56 ALVESCO HFA 56 placebo controlled Phase III 56 pain palliation 56 metabolic parameters 56 guanfacine extended release 56 PPAR gamma agonists 56 VITAL Trial 56 FROVA 56 rHuPH# 56 AstraZeneca Toprol XL 56 Onbrez Breezhaler 56 Celebrex celecoxib 56 XGEVA 56 GRN#L 56 TRIOLEX 56 certolizumab 56 FASLODEX 56 evaluating mipomersen 56 NUEDEXTA 56 CHAMPION PCI 56 APF# 56 severe gastroparesis 56 Navelbine ® 56 Abilify aripiprazole 56 mTOR inhibitor 56 mometasone 56 omalizumab 56 AZOR 56 limiting toxicity 56 VADT 56 #mg dose [001] 56 antipsychotic efficacy 56 Randomized Phase 56 GnRH antagonist 56 BRAF inhibitor 56 SPIRIVA HandiHaler 56 reboxetine 56 Azedra ™ 56 valopicitabine 56 Huntexil 56 cetilistat 56 alicaforsen enema